We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » RyMed Receives Warning Letter Despite Response to Form 483
RyMed Receives Warning Letter Despite Response to Form 483
March 30, 2007
The FDA told RyMed Technologies during a March meeting that the firm’s initial response to a Form 483 regarding alleged current good manufacturing practice violations satisfied the agency’s concerns, according to the firm.